Home Biotech Stocks

Biotech Stocks

Random

Pfizer Inc. (NYSE:PFE) Phase II Clinical Trial Of Lorlatinib Shows Promise

ME Contributor - October 17, 2017

Here’s What Just Happened With Pfizer Inc. (NYSE:PFE)

International Business Machines Corp. (NYSE:IBM) Wants To Sell AI GlaxoSmithKline PLC (NYSE:GSK)

Hurricane Maria To Impact Medtronic plc. (NYSE:MDT) Financial Results

Here’s A Look At Prothena Corporation PLC (NASDAQ:PRTA)’s Upcoming Milestones

Boston Scientific Corporation (NYSE:BSX) Plans Study on Subcutaneous Implantable Defibrillator

ME Contributor - April 20, 2017

enGene Shines with a Host of Big Name Collaborations

ME Contributor - January 13, 2016

Boston Scientific Corporation (NYSE:BSX) CEO Mike Mahoney Reveals Long Term Growth...

ME Contributor - June 30, 2017

Here’s What Just Happened With Puma Biotechnology, Inc. (NASDAQ:PBYI)

ME Contributor - May 25, 2017

Deconstructing the Lipocine Inc (NASDAQ:LPCN) Complete Response Letter

ME Contributor - June 30, 2016

Remicade Biosimilar From Johnson & Johnson (NYSE:JNJ) Threatened By Incheon-Based Celltrion

ME Contributor - April 22, 2016

Is The Cidara Therapeutics Inc (NASDAQ:CDTX) Crash An Opportunity?

ME Contributor - February 22, 2017

Inside The FDA: Why Cempra Inc (NASDAQ:CEMP) Solithromycin Yes Vote Isn’t...

Market Exclusive Intelligence - November 16, 2016

Biotech Movers And Shakers: Ocular Therapeutix Inc (NASDAQ:OCUL) and Argos Therapeutics...

ME Contributor - February 23, 2017

FDA Approves Medtronic plc (NYSE:MDT) Claria MRI Quad CRT-D SureScan

ME Contributor - November 15, 2016

12 3...145 Page 1 of 145

EDITOR PICKS

Here’s What Just Happened With Prothena And Kamada

April 24, 2018

Market Exclusive Daily Roundup April 24th

April 24, 2018

Here’s Why The Committee News Is So Important For GW Pharmaceuticals

April 23, 2018

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.